ScholarLens Back to search
2013•Shanghai Journal of Traditional Chinese MedicineRequires access

Combination of “Lidan Heluo Decoction” and routine treatment for primary biliary cirrhosis

Zhang Dong-hu

Open publisher page 0 citations

Abstract

Objective To observe the clinical efficacy ofLidan Heluo Decoctionin treating primary biliary cirrhosis(PBC).Methods Sixty-five PBC patients were randomized into two groups:control group in which 32cases were treated by Ursodeoxycholic Acid Capsules and Compound Glycyrrhizin Tablets,and treatment group in which 33cases were treated byLidan Heluo Decoctionadditionally,with the course of one month.Results The total effective rate was 62.50%in the control group and 87.88%in the treatment group(P0.01);after treatment,the levels ofγ-GGT,ALP,TBIL, AST and ALT were decreased in both two groups(P0.05,P0.01),and the levels in treatment group were lower than that of the control group(P 0.05).Conclusion Lidan Heluo Decoctioncan improve the clinical efficacy and liver function in PBC patients.

About this research paper

What this paper is about

Objective To observe the clinical efficacy ofLidan Heluo Decoctionin treating primary biliary cirrhosis(PBC).Methods Sixty-five PBC patients were randomized into two groups:control group in which 32cases were treated by Ursodeoxycholic Acid Capsules and Compound Glycyrrhizin Tablets,and treatment group in which 33cases were treated byLidan Heluo Decoctionadditionally,with the course of one month.Results The total effective rate was 62.50%in the control group and 87.88%in the treatment group(P0.01);after treatment,the levels ofγ-GGT,ALP,TBIL, AST and ALT were decreased in both two groups(P0.05,P0.01),and the levels in treatment group were lower than that of the control group(P 0.05).Conclusion Lidan Heluo Decoctioncan improve the clinical efficacy and liver function in PBC patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical efficacy ofLidan Heluo Decoctionin treating primary biliary cirrhosis(PBC).Methods Sixty-five PBC patients were randomized into two groups:control group in which 32cases were treated by Ursodeoxycholic Acid Capsules and Compound Glycyrrhizin Tablets,and treatment group in which 33cases were treated byLidan Heluo Decoctionadditionally,with the course of one month.Results The total effective rate was 62.50%in the control group and 87.88%in the treatment group(P0.01);after treatment,the levels ofγ-GGT,ALP,TBIL, AST and ALT were decreased in both two groups(P0.05,P0.01),and the levels in treatment group were lower than that of the control group(P 0.05).Conclusion Lidan Heluo Decoctioncan improve the clinical efficacy and liver function in PBC patients.

Key concepts: Medicine, Ursodeoxycholic acid, Decoction, Gastroenterology, Primary biliary cirrhosis, Internal medicine, Glycyrrhizin, Cirrhosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Combination of “Lidan Heluo Decoction” and routine treatment for primary biliary cirrhosis — Research Paper | ScholarLens